Pharmaceutical Technology Europe-09-01-2012

Pharmaceutical Technology Europe

European Commission Investigates Pay-to-Delay Deals

September 01, 2012

24

9

Following an inquiry in 2009 that suggested the launch of various generic drugs was being delayed by anticompetitive business practices, the European Commission (EC) has been closely monitoring deals for potential breaches of the EU's antitrust rules.

Regulatory Intervention in Paediatric Medicines

September 01, 2012

Industry Insider

24

9

Regulators in both the EU and the US have attempted to stimulate paediatric-drug development with incentives offering extended periods of patent protection, but are these actions having the desired effects?

Pharmaceutical Technology Europe, September 2012 Issue (PDF)

September 01, 2012

Issue PDF

24

9

Click the title above to open the Pharmaceutical Technology Europe September 2012 issue in an interactive PDF format.